Universe Pharmaceuticals Stock Performance
| UPC Stock | USD 4.10 0.03 0.74% |
The entity has a beta of 0.99, which indicates possible diversification benefits within a given portfolio. Universe Pharmaceuticals returns are very sensitive to returns on the market. As the market goes up or down, Universe Pharmaceuticals is expected to follow. At this point, Universe Pharmaceuticals has a negative expected return of -0.0232%. Please make sure to validate Universe Pharmaceuticals' accumulation distribution, and the relationship between the value at risk and day typical price , to decide if Universe Pharmaceuticals performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Universe Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Universe Pharmaceuticals is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders. ...more
| Begin Period Cash Flow | 5.3 M | |
| Total Cashflows From Investing Activities | -361.3 K |
Universe Pharmaceuticals Relative Risk vs. Return Landscape
If you would invest 482.00 in Universe Pharmaceuticals on October 29, 2025 and sell it today you would lose (72.00) from holding Universe Pharmaceuticals or give up 14.94% of portfolio value over 90 days. Universe Pharmaceuticals is generating negative expected returns assuming volatility of 7.1772% on return distribution over 90 days investment horizon. In other words, 64% of stocks are less volatile than Universe, and above 99% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Universe Pharmaceuticals Target Price Odds to finish over Current Price
The tendency of Universe Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 4.10 | 90 days | 4.10 | about 43.38 |
Based on a normal probability distribution, the odds of Universe Pharmaceuticals to move above the current price in 90 days from now is about 43.38 (This Universe Pharmaceuticals probability density function shows the probability of Universe Stock to fall within a particular range of prices over 90 days) .
Considering the 90-day investment horizon Universe Pharmaceuticals has a beta of 0.99. This usually implies Universe Pharmaceuticals market returns are highly-sensitive to returns on the market. As the market goes up or down, Universe Pharmaceuticals is expected to follow. Additionally Universe Pharmaceuticals has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Universe Pharmaceuticals Price Density |
| Price |
Predictive Modules for Universe Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Universe Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Universe Pharmaceuticals Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Universe Pharmaceuticals is not an exception. The market had few large corrections towards the Universe Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Universe Pharmaceuticals, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Universe Pharmaceuticals within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.1 | |
β | Beta against Dow Jones | 0.99 | |
σ | Overall volatility | 0.42 | |
Ir | Information ratio | -0.01 |
Universe Pharmaceuticals Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Universe Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Universe Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Universe Pharmaceuticals generated a negative expected return over the last 90 days | |
| Universe Pharmaceuticals has high historical volatility and very poor performance | |
| Universe Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the last year's revenue of 23.02 M. Reported Net Loss for the year was (8.73 M) with profit before taxes, overhead, and interest of 5.87 M. | |
| Universe Pharmaceuticals has about 28.58 M in cash with (9.51 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.31. |
Universe Pharmaceuticals Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Universe Stock often depends not only on the future outlook of the current and potential Universe Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Universe Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 6077.00 | |
| Cash And Short Term Investments | 29.5 M |
Universe Pharmaceuticals Fundamentals Growth
Universe Stock prices reflect investors' perceptions of the future prospects and financial health of Universe Pharmaceuticals, and Universe Pharmaceuticals fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Universe Stock performance.
| Return On Equity | -0.23 | ||||
| Return On Asset | -0.0827 | ||||
| Profit Margin | (0.50) % | ||||
| Operating Margin | (0.25) % | ||||
| Current Valuation | (37.25 M) | ||||
| Shares Outstanding | 563.34 K | ||||
| Price To Earning | 3.02 X | ||||
| Price To Book | 0.04 X | ||||
| Price To Sales | 0.12 X | ||||
| Revenue | 23.02 M | ||||
| EBITDA | (7.36 M) | ||||
| Cash And Equivalents | 28.58 M | ||||
| Cash Per Share | 1.31 X | ||||
| Total Debt | 7.99 M | ||||
| Debt To Equity | 0.07 % | ||||
| Book Value Per Share | 97.96 X | ||||
| Cash Flow From Operations | (9.51 M) | ||||
| Earnings Per Share | (255.68) X | ||||
| Total Asset | 67.95 M | ||||
| Retained Earnings | (10.17 M) | ||||
About Universe Pharmaceuticals Performance
By analyzing Universe Pharmaceuticals' fundamental ratios, stakeholders can gain valuable insights into Universe Pharmaceuticals' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Universe Pharmaceuticals has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Universe Pharmaceuticals has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Universe Pharmaceuticals INC, a pharmaceutical company, engages in the manufacture, marketing, distribution, and sale of traditional Chinese medicine derivative products in China. Universe Pharmaceuticals INC is a subsidiary of Sununion Holding Group Limited. Universe Pharmaceuticals is traded on NASDAQ Exchange in the United States.Things to note about Universe Pharmaceuticals performance evaluation
Checking the ongoing alerts about Universe Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Universe Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Universe Pharmaceuticals generated a negative expected return over the last 90 days | |
| Universe Pharmaceuticals has high historical volatility and very poor performance | |
| Universe Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the last year's revenue of 23.02 M. Reported Net Loss for the year was (8.73 M) with profit before taxes, overhead, and interest of 5.87 M. | |
| Universe Pharmaceuticals has about 28.58 M in cash with (9.51 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.31. |
- Analyzing Universe Pharmaceuticals' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Universe Pharmaceuticals' stock is overvalued or undervalued compared to its peers.
- Examining Universe Pharmaceuticals' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Universe Pharmaceuticals' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Universe Pharmaceuticals' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Universe Pharmaceuticals' stock. These opinions can provide insight into Universe Pharmaceuticals' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Universe Stock analysis
When running Universe Pharmaceuticals' price analysis, check to measure Universe Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Universe Pharmaceuticals is operating at the current time. Most of Universe Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Universe Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Universe Pharmaceuticals' price. Additionally, you may evaluate how the addition of Universe Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| AI Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |